Prospective Screening for Osteoporosis; Australian Primary Care Evaluation of Clinical Tests

Not Applicable

Active, not recruiting

• Conditions: Osteoporosis; Musculoskeletal - Osteoporosis

• Registration Number: ACTRN12608000529347
• Lead Sponsor: Prof Leon Piterman AM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-10-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 4000

Inclusion Criteria

Women aged 70 years and over, who have not had a previous diagnosis of osteoporosis.

Exclusion Criteria

Inability to read or give informed consent in English; previous diagnosis of osteoporosis; a history of a DEXA scan in the last 2 years; significant chronic disease that in itself is an indication for the patient to have a DEXA scan, a history of more than 6 months use of raloxifene, bisphosphonate, strontium ranelate, 1,25 vitamin D or parathyroid hormone (PTH) analogue; use of systemic hormone replacement therapy (HRT) within the last 2 years.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalance of osteoporosis and verterbral fracture in a primary care setting, will be determined using the reports from radiology tests.[14 November 2008, study close: all patient data submitted for analysis]

Secondary Outcome Measures

Name	Time	Method
Examine predictors of osteoporosis and fracture using the survey data provided and a logistical regression model.[End of December 2008: Database lock]